Executive Director, U.S. Public Policy (CMS, HHS & Payment Policy)

<div class="content-intro"><p><span style="text-decoration: underline;"><strong><span data-contrast="auto">Mavericks Wanted</span></strong><span data-ccp-props="{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}">&nbsp;</span></span></p> <p><span data-contrast="auto">When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on</span>&nbsp;<br><span data-contrast="auto"> </span>&nbsp;<br><span data-contrast="auto">In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare&nbsp;disease, and&nbsp;develop life-changing medicines for patients with unmet needs as fast as humanly possible. </span>&nbsp;<br><span data-contrast="auto"> </span>&nbsp;<br><span data-contrast="auto">Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll&nbsp;ask&nbsp;"why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical &amp; thoughtful use of AI to improve clarity, speed, and quality of work.</span><span data-ccp-props="{&quot;134233117&quot;:true,&quot;134233118&quot;:true,&quot;201341983&quot;:0,&quot;335559740&quot;:240}">&nbsp;</span></p></div><p>&nbsp;</p> <p><strong><u>What You'll Do </u></strong><span style="color: rgb(255, 255, 255);" data-olk-copy-source="MessageBody">#LI-TC1</span></p> <p><span style="font-size: 14px;">BridgeBio is establishing a dedicated, senior U.S. public policy leadership role focused on CMS, HHS, and coverage and payment policy that directly affects patient access and innovation across the BridgeBio portfolio.</span></p> <p><span style="font-size: 14px;">The Executive Director, U.S. Public Policy will </span><strong><span style="font-size: 14px;">own the end-to-end U.S. public policy strategy</span></strong><span style="font-size: 14px;"> related to Medicare, Medicaid, and payment models, and will be